Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $105,410,074.36
- Feb. 11, 2025
- Alec Machiels
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 4, 2024 | Insider | 2,751 | $60.05 | Sell | $165,197.55 | |
Dec. 26, 2023 | Insider | 68 | $57.86 | Sell | $3,934.48 | |
Dec. 19, 2023 | General Counsel | 3,905 | $57.23 | Sell | $223,483.15 | |
Dec. 1, 2023 | Insider | 10,000 | $60.00 | Sell | $600,000.00 | |
Nov. 21, 2023 | CEO | 5,000 | $48.80 | Sell | $244,000.00 | |
Nov. 17, 2023 | Director | 1,250 | $47.74 | Sell | $59,675.00 | |
Nov. 8, 2023 | Insider | 12,000 | $47.27 | Sell | $567,240.00 | |
Oct. 23, 2023 | CAO | 132 | $46.04 | Sell | $6,077.28 | |
Oct. 23, 2023 | Insider | 131 | $46.04 | Sell | $6,031.24 | |
Oct. 17, 2023 | Director | 1,250 | $48.50 | Sell | $60,625.00 | |
Oct. 9, 2023 | Insider | 12,000 | $40.38 | Sell | $484,560.00 | |
Sept. 18, 2023 | Director | 1,250 | $45.00 | Sell | $56,250.00 | |
Sept. 18, 2023 | Insider | 20,350 | $44.27 | Sell | $900,894.50 | |
Sept. 15, 2023 | Director | 1,250 | $45.34 | Sell | $56,675.00 | |
Sept. 8, 2023 | Insider | 12,000 | $42.87 | Sell | $514,440.00 | |
Sept. 1, 2023 | CEO | 150,000 | $41.75 | Sell | $6,262,500.00 | |
Aug. 31, 2023 | CAO | 551 | $41.23 | Sell | $22,717.73 | |
Aug. 8, 2023 | Insider | 12,000 | $23.66 | Sell | $283,920.00 | |
July 17, 2023 | Director | 1,250 | $64.79 | Sell | $80,987.50 | |
July 10, 2023 | Insider | 12,000 | $84.55 | Sell | $1,014,600.00 | |
July 3, 2023 | CFO | 6,779 | $89.97 | Sell | $609,906.63 | |
July 3, 2023 | General Counsel | 8,510 | $89.98 | Sell | $765,729.80 | |
June 20, 2023 | Director | 1,250 | $88.41 | Sell | $110,512.50 | |
June 8, 2023 | Insider | 12,000 | $91.35 | Sell | $1,096,200.00 | |
June 5, 2023 | CFO | 69,779 | $88.80 | Sell | $6,196,375.20 | |
June 1, 2023 | Insider | 5,000 | $86.00 | Sell | $430,000.00 | |
May 17, 2023 | Director | 1,250 | $88.66 | Sell | $110,825.00 | |
May 16, 2023 | CEO | 30,000 | $85.66 | Sell | $2,569,800.00 | |
May 8, 2023 | Insider | 12,000 | $92.39 | Sell | $1,108,680.00 | |
May 3, 2023 | Insider | 5,000 | $82.71 | Sell | $413,550.00 | |
April 18, 2023 | CEO | 30,000 | $82.02 | Sell | $2,460,600.00 | |
April 17, 2023 | Director | 1,250 | $81.05 | Sell | $101,312.50 | |
April 10, 2023 | Insider | 12,000 | $78.21 | Sell | $938,520.00 | |
April 3, 2023 | Insider | 5,000 | $75.00 | Sell | $375,000.00 | |
April 3, 2023 | Director | 500 | $74.05 | Sell | $37,025.00 | |
March 21, 2023 | CEO | 30,000 | $62.74 | Sell | $1,882,200.00 | |
March 17, 2023 | Director | 1,250 | $64.03 | Sell | $80,037.50 | |
March 8, 2023 | Insider | 12,000 | $63.79 | Sell | $765,480.00 | |
Feb. 23, 2023 | Insider | 1,646 | $68.76 | Sell | $113,178.96 | |
Feb. 8, 2023 | Insider | 12,000 | $54.45 | Sell | $653,400.00 | |
Feb. 3, 2023 | Insider | 5,000 | $55.85 | Sell | $279,250.00 | |
Jan. 30, 2023 | Insider | 883 | $52.76 | Sell | $46,587.08 | |
Jan. 23, 2023 | Insider | 2,955 | $51.58 | Sell | $152,418.90 | |
Jan. 17, 2023 | Director | 1,250 | $52.42 | Sell | $65,525.00 | |
Jan. 9, 2023 | Insider | 12,000 | $46.08 | Sell | $552,960.00 | |
Jan. 5, 2023 | Insider | 2,500 | $48.79 | Sell | $121,975.00 | |
Jan. 3, 2023 | Director | 500 | $50.70 | Sell | $25,350.00 | |
Jan. 3, 2023 | Insider | 5,000 | $50.70 | Sell | $253,500.00 | |
Dec. 19, 2022 | CEO | 28,200 | $52.06 | Sell | $1,468,092.00 | |
Dec. 15, 2022 | Director | 1,250 | $52.35 | Sell | $65,437.50 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Cedric Francois, Federico Grossi, Pascal Deschatelets, David O Watson, A. Sinclair Dunlop, Mark Jeffrey Delong, Timothy Eugene Sullivan, Adam J Townsend, Lukas Scheibler, James George Chopas, Jeffrey Eisele, Nur Nicholson, Nicole D Perry, Morningside Venture Investment, Karen Lewis, Caroline Baumal, Machiels Alec, Global Strategic Fund I Venbio, Deschatelets Pascal, Victoria L Brown, and Victoria L. Brown
The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $35,626,981.58.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on Feb. 11, 2025.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.